$3.36 million Commercialization Readiness Pilot award from the National Institute on Aging for completing the development of CogniMIR™, a blood-based test for early detection of mild cognitive impairment and Alzheimer’s disease. $498,572 SBIR Phase I award from the National Institute for Neurological Disorders and Stroke for the development of biomarkers for Rett syndrome.